GuidelineAnnals of the rheumatic diseases2021

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.

Peter Nash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.